TW202346839A - 測定體液中至少一種分析物之濃度的方法及裝置 - Google Patents
測定體液中至少一種分析物之濃度的方法及裝置 Download PDFInfo
- Publication number
- TW202346839A TW202346839A TW112104804A TW112104804A TW202346839A TW 202346839 A TW202346839 A TW 202346839A TW 112104804 A TW112104804 A TW 112104804A TW 112104804 A TW112104804 A TW 112104804A TW 202346839 A TW202346839 A TW 202346839A
- Authority
- TW
- Taiwan
- Prior art keywords
- color
- optical test
- training set
- test strip
- color formation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 97
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 91
- 239000012491 analyte Substances 0.000 title claims abstract description 38
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 141
- 238000000691 measurement method Methods 0.000 claims abstract description 70
- 238000004458 analytical method Methods 0.000 claims abstract description 41
- 238000012360 testing method Methods 0.000 claims description 396
- 230000003287 optical effect Effects 0.000 claims description 259
- 238000012549 training Methods 0.000 claims description 154
- 239000010839 body fluid Substances 0.000 claims description 86
- 239000003153 chemical reaction reagent Substances 0.000 claims description 80
- 238000005259 measurement Methods 0.000 claims description 63
- 238000003556 assay Methods 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 238000004422 calculation algorithm Methods 0.000 claims description 11
- 238000010801 machine learning Methods 0.000 claims description 9
- 239000003086 colorant Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 4
- 238000009795 derivation Methods 0.000 claims description 3
- 238000005755 formation reaction Methods 0.000 abstract description 134
- 238000003860 storage Methods 0.000 abstract description 26
- 238000004590 computer program Methods 0.000 abstract description 20
- 239000008280 blood Substances 0.000 description 40
- 210000004369 blood Anatomy 0.000 description 40
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 35
- 239000008103 glucose Substances 0.000 description 35
- 238000001514 detection method Methods 0.000 description 16
- 239000000758 substrate Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 210000003722 extracellular fluid Anatomy 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000008105 immune reaction Effects 0.000 description 4
- 230000015654 memory Effects 0.000 description 4
- 108091023037 Aptamer Proteins 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 238000007705 chemical test Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000003936 working memory Effects 0.000 description 2
- 241001270131 Agaricus moelleri Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000013527 convolutional neural network Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011545 laboratory measurement Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/251—Colorimeters; Construction thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/272—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration for following a reaction, e.g. for determining photometrically a reaction rate (photometric cinetic analysis)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156307.5 | 2022-02-11 | ||
| EP22156307 | 2022-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202346839A true TW202346839A (zh) | 2023-12-01 |
Family
ID=80682739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112104804A TW202346839A (zh) | 2022-02-11 | 2023-02-10 | 測定體液中至少一種分析物之濃度的方法及裝置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240418728A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4476532B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507363A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240144932A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118696227A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247869A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202346839A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023152266A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025162741A1 (en) * | 2024-01-30 | 2025-08-07 | Roche Diabetes Care Gmbh | Method of detecting an analyte in a sample of bodily fluid |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009145250A1 (ja) | 2008-05-29 | 2009-12-03 | アークレイ株式会社 | 免疫分析装置および免疫分析方法 |
| KR101669739B1 (ko) | 2011-11-14 | 2016-10-27 | 에프. 호프만-라 로슈 아게 | 샘플에서 적어도 하나의 분석물을 검출하기 위한 분석 장치 |
| US9311520B2 (en) | 2012-08-08 | 2016-04-12 | Scanadu Incorporated | Method and apparatus for performing and quantifying color changes induced by specific concentrations of biological analytes in an automatically calibrated environment |
| US20150247874A1 (en) | 2014-02-28 | 2015-09-03 | Government Of The United States As Represented By The Secretary Of The Air Force | Metal nanoparticle-aptamer conjugates for detection of small molecules and in-the-field use thereof |
| EP2916117A1 (en) | 2014-03-05 | 2015-09-09 | Scanadu Incorporated | Quantifying color changes of chemical test pads induced by specific concentrations of biological analytes under different lighting conditions |
| TWI810247B (zh) | 2018-02-26 | 2023-08-01 | 瑞士商赫孚孟拉羅股份公司 | 用於校準和使用攝影機來偵測樣品中的分析物之方法及系統 |
| US11243160B2 (en) * | 2018-03-28 | 2022-02-08 | Detekt Biomedical, Llc | Custom optical reference calibrator fabrication system |
| US11112406B2 (en) | 2018-06-15 | 2021-09-07 | Reliant Immune Diagnostics, Inc. | System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results |
| EP3983805B1 (en) * | 2019-06-14 | 2024-06-26 | DeLaval Holding AB | System for determining validity of a lateral flow test result |
-
2023
- 2023-02-10 WO PCT/EP2023/053265 patent/WO2023152266A1/en not_active Ceased
- 2023-02-10 CA CA3247869A patent/CA3247869A1/en active Pending
- 2023-02-10 JP JP2024547546A patent/JP2025507363A/ja active Pending
- 2023-02-10 CN CN202380021184.7A patent/CN118696227A/zh active Pending
- 2023-02-10 KR KR1020247026619A patent/KR20240144932A/ko active Pending
- 2023-02-10 EP EP23704139.7A patent/EP4476532B1/en active Active
- 2023-02-10 TW TW112104804A patent/TW202346839A/zh unknown
-
2024
- 2024-07-31 US US18/789,842 patent/US20240418728A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4476532A1 (en) | 2024-12-18 |
| WO2023152266A1 (en) | 2023-08-17 |
| CA3247869A1 (en) | 2023-08-17 |
| CN118696227A (zh) | 2024-09-24 |
| JP2025507363A (ja) | 2025-03-18 |
| EP4476532B1 (en) | 2026-01-28 |
| KR20240144932A (ko) | 2024-10-04 |
| EP4476532C0 (en) | 2026-01-28 |
| US20240418728A1 (en) | 2024-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI795453B (zh) | 基於顏色形成反應執行分析量測的方法及裝置 | |
| EP3759465B1 (en) | Methods and systems for calibrating and using a camera for detecting an analyte in a sample | |
| US12287327B2 (en) | Method of determining a concentration of an analyte in a bodily fluid | |
| US20230084800A1 (en) | Method of evaluating the quality of a color reference card | |
| US20240402088A1 (en) | Methods and devices for performing an analytical measurement | |
| US20240418728A1 (en) | Methods and devices for determining the concentration of at least one analyte in a bodily fluid | |
| US9869631B2 (en) | Analysis device and method of determining mounted state of cartridge of the analysis device | |
| HK40117003A (en) | Methods and devices for determining the concentration of at least one analyte in a bodily fluid | |
| EP4476525B1 (en) | Method of determining a color expectation range for assessing the plausibility of an assumed reaction time value used in an analytical measurement based on a color formation reaction, system and mobile device | |
| HK40116947A (en) | Methods and devices for determining the concentration of at least one analyte in a bodily fluid | |
| RU2824292C2 (ru) | Способ определения концентрации аналита в физиологической жидкости | |
| EP3989823B1 (en) | Determination of a concentration of an analyte in a bodily fluid by using a mobile device with a camera | |
| WO2024184138A1 (en) | Methods and devices for providing blacklist information on the suitability of a mobile device for performing analytical measurements | |
| TW202517999A (zh) | 檢測體液之樣品中的分析物之方法及行動裝置 | |
| HK40079521A (en) | Method of determining a concentration of an analyte in a bodily fluid |